You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

Saudi Chemical Co. Holding obtained the Saudi Food and Drug Authority’s (SFDA) approval to register Ticagrelor as a fully ...

Read here for an analysis of Palantir's unsustainable valuation, lack of non-adjusted margins, and existential business model ...

Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...

MALMÖ, SWEDEN / ACCESS Newswire / February 7, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Q4 and Full Year Report for 2024 (January - December), which is ...

TIER IV, the pioneering force behind the world's first open-source software for autonomous driving, and Nihon Kotsu, Tokyo's largest taxi company, launched a pioneering project in February to collect ...

Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) ...

Palantir is a data analytics and software development company, and has risen dramatically from its market debut in 2020. See ...

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) signed a SAR 36.1 million revolving short-term credit facility, via its ...